MORPHINE SULFATE RELATED COMPOUND A, UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD

Hazard statements (CLP)

H301, H301+H331, H317, H331, H334, H336

Code

Statements

H301

Toxic if swallowed

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture Acute toxicity, (Category 3) H301: Toxic if swallowed Acute toxicity, (Category 3) H331: Toxic if inhaled Respiratory sensitization, H334: May cause allergy or asthma Category 1) symptoms or breathing difficulties if inhaled Skin sensitization, (Category H317: May cause an allergic skin reaction Specific target organ toxicity - H336: May cause drowsiness or dizziness. single exposure, (Category 3), Central nervous system

Signal word

Danger

Hazard statements

H301 + H331 Toxic if swallowed or if inhaled. H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H336 May cause drowsiness or dizziness.

Precautionary statements

P261 Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P280 Wear protective gloves. P284 Wear respiratory protection. P301 + P330 + P331 + IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P310 Immediately call a POISON CENTER/ doctor. P304 + P340 + P311 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor. P403 + P233 Store in a well-ventilated place. Keep container tightly closed.

Supplemental label elements

none

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Acute toxicity, (Category 3) H301: Toxic if swallowed. Acute toxicity, (Category 3) H331: Toxic if inhaled. Respiratory sensitization, H334: May cause allergy or asthma (Category 1) symptoms or breathing difficulties if inhaled. Skin sensitization, (Category 1) H317: May cause an allergic skin reaction. Specific target organ toxicity - H336: May cause drowsiness or dizziness. single exposure, (Category 3), Central nervous system